Five months before Colorado's Prescription Drug Affordability Board will vote on how much to cap the cost of Amgen's Enbrel, the drugmaker filed a lawsuit.

On March 26, the FDA approved a drug from Merck to treat adults with pulmonary arterial hypertension — a rare, progressive lung condition. 

About 30 pharmacists and pharmacy technicians at a Las Vegas CVS Omnicare filed to unionize March 25, making them the first in their industry to seek unionization. 

More than a year after the FDA yanked away authorization from Evusheld, a monoclonal antibody treatment for COVID-19, the agency granted emergency use authorization to a new COVID-19 preventive drug March 22. 

Wegovy and Ozempic maker Novo Nordisk has agreed to buy Cardior Pharmaceuticals for $1.11 billion. The acquisition is part of Novo Nordisk's larger strategy to build a portfolio of therapies in cardiovascular disease. 

A former CVS location is now occupied by a United Health Services pharmacy. 

On March 22, the FDA granted emergency use authorization to Pemgarda, a COVID-19 preventive medication, for patients 12 and older. 

The FDA has approved Duvyzat as the first nonsteroidal drug for patients with all genetic variants of Duchenne muscular dystrophy, the agency said March 21.

Researchers and pharmacists at West Virginia University are developing AI technology to streamline medication reconciliation in hospitals, or the standard of reviewing a patient's drug regimen before discharges. 

Mark Cuban Cost Plus Drug Co. expanded its pharmacy network March 20 with a deal with grocery chain Albertsons, growing its drug discount offering by another thousand-plus locations.